| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Design Therapeutics, Inc. (DSGN) has 11 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. DSGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.65M | $41.94M | - | |
| CEO | 750.0K | $11.85M | - | |
| COO | 375.0K | $5.92M | - | |
| Other | 250.0K | $3.95M | - | |
| Other | 150.0K | $2.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | Thacker Justin | Vice President, Finance | Buy | 17,500 | $20.00 | $350,000.00 | New | -22.5% | -45.8% | |
| Mar 30, 2021 | Xu Stella67 | Director, 10% Owner | Buy | 10,000 | $20.00 | $200,000.00 | +0.2% | -22.5% | -45.8% | |
| Mar 30, 2021 | George Simeon | Director, 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +4.6% | -22.5% | -45.8% | |
| Mar 30, 2021 | William Arsani55 | Director | Buy | 700,000 | $20.00 | $14,000,000.00 | +34.4% | -22.5% | -45.8% |